Fundz

Enara Bio Appoints Scott Drutman as Chief Medical Officer

PRIVATEJan 08, 2026

Position

Chief Medical Officer

Company

Enara Bio

Scott Drutman
OxfordBiotechnologyHealth CareTherapeutics

Description

Enara Bio has appointed Scott Drutman, M.D., Ph.D. as its new Chief Medical Officer, bringing extensive expertise in translational medicine and immuno-oncology drug development. This appointment comes as the company prepares to advance its ENA101 into clinical development in 2026.

Quick answer

Enara Bio Appoints Scott Drutman as Chief Medical Officer (January 8, 2026). Enara Bio is based in Oxford, England, United Kingdom.

Who is the new Chief Medical Officer at Enara Bio?
Enara Bio named Scott Drutman Chief Medical Officer, announced January 8, 2026.
What did Enara Bio announce on January 8, 2026?
Enara Bio has appointed Scott Drutman, M.D., Ph.D. as its new Chief Medical Officer, bringing extensive expertise in translational medicine and immuno-oncology drug development. This appointment comes as the company prepares to advance its ENA101 into clinical development in 2026.
What does Enara Bio do?
Enara Bio is a biopharmaceutical company pioneering the development of bispecific T-cell engagers directed against Dark Antigen® and other emerging targets.
Where is Enara Bio based?
Enara Bio is based in Oxford, England, United Kingdom.
Which similar companies made leadership changes around the same time?
Archeus Technologies (January 7, 2026), Rhapsogen (January 6, 2026), Mezzion Pharma (January 6, 2026) and NuCana (January 6, 2026) also announced leadership changes within 45 days of Enara Bio.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Enara Bio, and when

A new leader at Enara Bio brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Enara Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Enara Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Enara Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Enara Bio

Location

Oxford, England, United Kingdom

About

Enara Bio is a biopharmaceutical company pioneering the development of bispecific T-cell engagers directed against Dark Antigen® and other emerging targets. The company focuses on delivering innovative therapies in oncology and immunology. With a strong emphasis on research and development, Enara is positioned at the forefront of transformative cancer treatments. Their goal is to develop novel immunotherapies that provide durable clinical benefits to cancer patients.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Enara Bio changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Stacey
Likely contact at this company
••••••••@••••••••

See Stacey's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Enara Bio's next move

Learn about Strategic plan

Enara Bio changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.